B
Bernard Amory
Researcher at Jones Day
Publications - 7
Citations - 4
Bernard Amory is an academic researcher from Jones Day. The author has contributed to research in topics: European union & Medicine. The author has an hindex of 1, co-authored 4 publications receiving 4 citations.
Papers
More filters
Les politiques de clémence en Europe
Laurence Idot,Catherine Prieto,Céline Gauer,Bernard Amory,Francesca Marchini Càmia,Jean-Christophe Roda,Christophe Lemaire,Marie-Barde Girard +7 more
TL;DR: Inventes il y a peu, a l'origine decries, les programmes de clemence se sont rapidement reveles un outil tres efficace de detection des ententes.
The EU Court of Justice upholds the Commission's first withdrawal of immunity for cartel whistleblower but finds the General Court failed to timely adjudicate (Deltafina / FLS Plast)
TL;DR: The European Court of Justice has upheld a €30 million fine against cartel whistleblower Deltafina, which was imposed following the withdrawal of the conditional immunity as a result of the…
The EU Commission adopts a proposal for a regulation on foreign subsidies distorting the internal market
Françoise Labousse,Bernard Amory,Renato Antonini,Charles de Navacelle,Kaarli Harry Eichhorn,Eva Monard +5 more
TL;DR: The European Commission has faced significant pressure from stakeholders to quickly address growing concerns over the distortive effects of foreign influence on the European Union's economic policies as discussed by the authors, and has responded to these concerns.
Beyond Alstom-Siemens: Is there a need to revise competition law goals? (New Frontiers of Antitrust - Paris, June 14th, 2019)
TL;DR: The present contributions were gathered following up the 10th edition of the "New Frontiers of Antitrust" annual Concurrences review Conference held in Paris on June 14th, 2019, at the French National Archives.
Journal ArticleDOI
Curage pédiculaire hépatique + bisegmentectomie IVb/V pour adénocarcinome de la vésicule biliaire (mini-invasive)
Bernard Amory,A.C. Chhang,R.C. Cheriff,Hassen Hentati,A. Atallah,Daniele Sommacale,Raffaele Brustia +6 more
TL;DR: In this article , a patient of 68 years was reported to have had a cholécystite aiguë lithiasique, a condition traité par antibiothérapie (Augmentin).